HIRSCHMAN ORIN 13D/13G Filings for Acer Therapeutics Inc. (ACER)

HIRSCHMAN ORIN 13D and 13G filings for Acer Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-03-17
4:06 pm
Sale		2021-03-1513GAcer Therapeutics Inc.
ACER		HIRSCHMAN ORIN0
0.000%		-982,446decrease
(Position Closed)		Filing
2021-02-10
4:13 pm
Purchase		2020-12-3113GAcer Therapeutics Inc.
ACER		HIRSCHMAN ORIN982,446
11.000%		982,446increase
(New Position)		Filing
2020-08-06
11:43 am
Purchase		2020-07-2213GAcer Therapeutics Inc.
ACER		HIRSCHMAN ORIN982,446
11.000%		430,406increase
(+77.97%)		Filing
2020-05-19
08:49 am
Purchase		2020-05-1413GAcer Therapeutics Inc.
ACER		HIRSCHMAN ORIN552,040
11.000%		552,040increase
(New Position)		Filing